Funding for this research was provided by:
National Cancer Institute (CA227064, CA208371)
Regenacy Pharmaceuticals Inc.
Received: 18 September 2018
Accepted: 21 September 2018
First Online: 1 October 2018
Ethics approval and consent to participate
: All animal work procedures were consistent with the National Institute of Health Guidelines for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee (IACUC) of M.D. Anderson Cancer Center.
: Not applicable.
: M.J. is employed by Regenacy Pharmaceuticals Inc. This study was supported in part by a research grant from Regenacy Pharmaceuticals to A.K. And C.J.H.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.